Non-Hodgkin lymphomas and ionizing radiation: case report and review of the literature Inge Schmitz-FeuerhakeRainer Frentzel-BeymeRoland Wolff Review Article Open access 08 December 2021 Pages: 243 - 250
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey David DingliJoana E. MatosScott B. Baver Original Article Open access 01 January 2022 Pages: 251 - 263
Langerhans cell histiocytosis in adults: a retrospective, single-center case series Stefano ChiaravalliAndrea FerrariMaura Massimino Original Article 11 October 2021 Pages: 265 - 272
Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1? Suellen Rodrigues MartinsSílvia Letícia de Oliveira ToledoMelina de Barros Pinheiro Original Article 19 October 2021 Pages: 273 - 280
The ratio of ATP11C/PLSCR1 mRNA transcripts has clinical significance in sickle cell anemia Diego A. Pereira-MartinsJuan L. Coelho-SilvaAntonio R. Lucena-Araujo Original Article 14 October 2021 Pages: 281 - 287
Pregnancy outcome in women with transfused beta-thalassemia in France Emilie VirotIsabelle ThuretArnaud Hot Original Article 20 October 2021 Pages: 289 - 296
Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement Danika Di GiacomoMartina QuintiniCristina Mecucci Original Article Open access 02 December 2021 Pages: 297 - 307
ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy Naama Keren-FroimGabriel HeeringJonathan Canaani Original Article 06 January 2022 Pages: 309 - 316
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study Alexandra-Cristina PaunescuChristiane Bergman CopieCaroline Besson Original Article 06 October 2021 Pages: 317 - 332
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study Alexandra‑Cristina PaunescuChristiane Copie BergmanCaroline Besson Correction 25 October 2021 Pages: 333 - 333
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma Mridula KrishnanR. Gregory BociekJulie M. Vose Original Article 20 October 2021 Pages: 335 - 340
Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients Carmen StanganelliDavi Coe TorresIrma Slavutsky Original Article 28 October 2021 Pages: 341 - 348
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience Yu-Wen WangXavier Cheng-Hong TsaiMing Yao Original Article 11 November 2021 Pages: 349 - 358
The role of KIAA1191 in the necroptotic pathway of multiple myeloma Zhao XuYifeng SunPeng Liu Original Article 06 January 2022 Pages: 359 - 367
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapy Xiao HuCherng-Horng WuCindy Varga Original Article 08 November 2021 Pages: 369 - 378
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study Oren PasvolskyShai ShimonyMoshe Yeshurun Original Article 09 October 2021 Pages: 379 - 387
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital Jorge Garcia BorregaJan-Michel HegerDennis A. Eichenauer Original Article Open access 20 October 2021 Pages: 389 - 395
Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience Fei YanNing LuChunji Gao Original Article 04 November 2021 Pages: 397 - 408
Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants Eun Sang YiJi Won LeeKeon Hee Yoo Original Article 02 November 2021 Pages: 409 - 419
Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts Riad El FakihFeras AlfraihMahmoud Aljurf Original Article 31 October 2021 Pages: 421 - 428
Rare presentation of myeloma with diffuse osteosclerotic lesions without features of POEMS Winston ZhengMichael Sze Yuan Low Letter to the Editor 12 February 2021 Pages: 429 - 430
Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids Tien-Chan HsiehOleg Sostin Letter to the Editor 18 February 2021 Pages: 431 - 432
Successful treatment by using a modified SMILE regimen and autologous hematopoietic stem cell transplantation in a pediatric primary EBV-positive nodular NK/T cell lymphoma patient Jian LiJuxin YeYongjun Fang Letter to the Editor 12 February 2021 Pages: 433 - 435
Treatment burden in multiple myeloma according to comorbidity in real life Ernesto Pérez PersonaItziar Oiartzabal OrmateguiJose María Guinea de Castro Letter to the Editor 05 March 2021 Pages: 437 - 440
Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma David Alvarez CespedesStephanie M. GallitanoDivaya Bhutani Letter to the Editor 15 April 2021 Pages: 441 - 442
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients William G. DunnMuxin S. GuGeorge S. Vassiliou Letter to the Editor Open access 01 March 2021 Pages: 443 - 445
Re: Risk factors and predictors of treatment responses and complications in immune thrombocytopenia Kundan MishraKamal Kant Sahu Letter to the Editor 02 March 2021 Pages: 447 - 448
Acute stroke in young adult secondary to moyamoya angiopathy unveiling HbE-β thalassemia Shambaditya DasKousik KarmakarBiman Kanti Ray Letter to the Editor 17 April 2021 Pages: 449 - 451
Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus Tomohiro KishiJun NakataMasaru Shibano Letter to the Editor 22 March 2021 Pages: 453 - 455
A case report of combined treatment of gilteritinib and LH-RH agonist for Fms-related tyrosine kinase 3 receptor mutation-positive acute myeloid leukemia and bone marrow metastasis of prostate cancer Takashi OnakaAiko Kato-OguraAkihito Yonezawa Letter to the Editor 12 April 2021 Pages: 457 - 458
Re: Hosokawa K et al. Assay sensitivity of flow cytometric PNH analysis Bruno BrandoArianna Gatti Letter to the Editor 22 February 2021 Pages: 459 - 460
Assay sensitivity of flow cytometric PNH analysis: response to Brando and Gatti Kohei HosokawaShinji Nakao Letter to the Editor 27 April 2021 Pages: 461 - 464
Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens Rikako TabataNobue SatoJunichiro Yuda Letter to the Editor 16 April 2021 Pages: 465 - 467
